Cited by 378Gut microbiota and healthGastrointestinal motility and disordersRegulation of Appetite and Obesity

Gut microbiota, enteroendocrine functions and metabolism

Cani, Patrice D, Everard, Amandine, Duparc, Thibaut·2013·Current Opinion in Pharmacology

Abstract

The gut microbiota affects host metabolism through a number of physiological processes. Emerging evidence suggests that gut microbes interact with the host through several pathways involving enteroendocrine cells (e.g. L cells). The activation of specific G protein coupled receptors expressed on L cells (e.g. GPR41, GPR43, GPR119 and TGR5) triggers the secretion of glucagon-like peptides (GLP-1 and GLP-2) and PYY. These gut peptides are known to control energy homeostasis, glucose metabolism, gut barrier function and metabolic inflammation. Here, we explore how crosstalk between the ligands produced by the gut microbiota (short chain fatty acids, or SCFAs), or produced by the host but influenced by gut microbes (endocannabinoids and bile acids), impact host physiology.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2013.09.008

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The microbiota regulates, via different mechanisms, some important physiological functions of the host, such as those related to energy expenditure, satiety and glucose homeostasis.

    “The microbiota regulates, via different mechanisms, some important physiological functions of the host, such as those related to energy expenditure, satiety and glucose homeostasis [10,11] .”
  • The GM can stimulate the release of peptides and hormones from enteroendocrine cells, which can have direct or indirect central effects.

    “The GM can stimulate the release of peptides and hormones from enteroendocrine cells, which can have direct or indirect central effects (22, 39).”
  • In the gut, the GM and its metabolites modulate gastrointestinal functions via effects on intestinal permeability, mucosal immune function, intestinal motility and sensitivity, and the ENS.

    “In the gut, the GM and its metabolites have been shown to modulate gastrointestinal functions via their effects on intestinal permeability (32–35), mucosal immune function (36–38), intestinal motility and sensitivity (39, 40), and the enteric nervous system (ENS) (21, 24, 25, 41).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cani, P. D., Everard, A., & Duparc, T.
Affiliations
Walloon Excellence in Lifesciences and Biotechnology (BE)
Corresponding author
Cani, Patrice D
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2013-12
Volume
13
Issue
6
Pages
935-940
ISSN
1471-4892 (ISSN-L)
OpenAlex
W2044719746
Cited by
378
References
61
Citations by year
2026: 16 · 2025: 17 · 2024: 21 · 2023: 26 · 2022: 31 · 2021: 37 · 2020: 45 · 2019: 34 · 2018: 48 · 2017: 36 · 2016: 29 · 2015: 21 · 2014: 16 · 2013: 1
FWCI
2.10
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
gut microbiota, enteroendocrine cells, L cells, G protein-coupled receptors, GPR41, GPR43, GPR119, TGR5, glucagon-like peptide-1, glucagon-like peptide-2, peptide YY, short-chain fatty acids, endocannabinoids, bile acids, energy homeostasis, glucose metabolism, intestinal barrier, metabolic inflammation
MeSH terms
Animals, Gastrointestinal Hormones, Humans, Enteroendocrine Cells, Gastrointestinal Tract, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review